Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Danaher ( (DHR) ) has provided an announcement.
On April 16, 2026, Danaher Corporation entered into a new $5.0 billion 364-day revolving credit facility with Bank of America as administrative agent and a syndicate of lenders, expiring April 15, 2027. The unsecured facility, which can be converted into a one-year term loan at maturity for a fee, bears variable interest tied to Term SOFR or a base rate plus ratings-dependent margins and includes a 4.0 basis point commitment fee on total commitments.
The agreement imposes a maximum consolidated leverage ratio of 0.65 to 1.00 and incorporates customary covenants restricting liens, major asset sales, certain mergers and non-permitted uses of proceeds, with specified change-of-control events constituting defaults. Danaher has guaranteed potential subsidiary borrower obligations, and intends to use the facility primarily to backstop its U.S. dollar commercial paper program and for general corporate purposes, reinforcing short-term liquidity and financial flexibility.
The most recent analyst rating on (DHR) stock is a Hold with a $205.00 price target. To see the full list of analyst forecasts on Danaher stock, see the DHR Stock Forecast page.
Spark’s Take on DHR Stock
According to Spark, TipRanks’ AI Analyst, DHR is a Neutral.
The score is driven primarily by solid financial quality (durable margins, strong free cash flow, and improving leverage), tempered by weaker recent growth/returns. Near-term technicals are notably soft (below key moving averages with negative MACD), and valuation is expensive (high P/E, low yield). Earnings call guidance and the Masimo deal add moderate support but include meaningful execution and end-market uncertainty.
To see Spark’s full report on DHR stock, click here.
More about Danaher
Danaher Corporation is a diversified global science and technology company that operates across life sciences, diagnostics and environmental and applied solutions. The group focuses on instruments, consumables and services that support healthcare, research and industrial customers, with significant exposure to U.S. dollar funding markets through its commercial paper activities.
Average Trading Volume: 4,189,809
Technical Sentiment Signal: Sell
Current Market Cap: $140.2B
See more data about DHR stock on TipRanks’ Stock Analysis page.